Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES AUROBINDO PHARMA ZYDUS LIFESCIENCES/
AUROBINDO PHARMA
 
P/E (TTM) x 20.8 12.9 160.8% View Chart
P/BV x 2.5 1.1 220.8% View Chart
Dividend Yield % 0.6 1.9 31.4%  

Financials

 ZYDUS LIFESCIENCES   AUROBINDO PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
AUROBINDO PHARMA
Mar-22
ZYDUS LIFESCIENCES/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs6741,064 63.3%   
Low Rs331584 56.7%   
Sales per share (Unadj.) Rs149.1400.3 37.2%  
Earnings per share (Unadj.) Rs22.745.7 49.7%  
Cash flow per share (Unadj.) Rs29.764.9 45.7%  
Dividends per share (Unadj.) Rs2.509.00 27.8%  
Avg Dividend yield %0.51.1 45.6%  
Book value per share (Unadj.) Rs166.1419.4 39.6%  
Shares outstanding (eoy) m1,023.74585.94 174.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.42.1 163.7%   
Avg P/E ratio x22.118.0 122.6%  
P/CF ratio (eoy) x16.912.7 133.3%  
Price / Book Value ratio x3.02.0 154.0%  
Dividend payout %11.019.7 55.9%   
Avg Mkt Cap Rs m514,277482,799 106.5%   
No. of employees `000NANA-   
Total wages/salary Rs m21,77734,509 63.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,652234,555 65.1%  
Other income Rs m2,3543,226 73.0%   
Total revenues Rs m155,006237,781 65.2%   
Gross profit Rs m34,42742,566 80.9%  
Depreciation Rs m7,13011,265 63.3%   
Interest Rs m1,270486 261.1%   
Profit before tax Rs m28,38134,040 83.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1177,256 70.5%   
Profit after tax Rs m23,26426,784 86.9%  
Gross profit margin %22.618.1 124.3%  
Effective tax rate %18.021.3 84.6%   
Net profit margin %15.211.4 133.5%  
BALANCE SHEET DATA
Current assets Rs m122,614181,227 67.7%   
Current liabilities Rs m78,39481,560 96.1%   
Net working cap to sales %29.042.5 68.2%  
Current ratio x1.62.2 70.4%  
Inventory Days Days9325 370.0%  
Debtors Days Days8062 127.9%  
Net fixed assets Rs m144,382155,104 93.1%   
Share capital Rs m1,024586 174.8%   
"Free" reserves Rs m168,972245,174 68.9%   
Net worth Rs m169,996245,760 69.2%   
Long term debt Rs m3,6212,492 145.3%   
Total assets Rs m266,996336,331 79.4%  
Interest coverage x23.371.0 32.9%   
Debt to equity ratio x00 210.1%  
Sales to assets ratio x0.60.7 82.0%   
Return on assets %9.28.1 113.3%  
Return on equity %13.710.9 125.6%  
Return on capital %17.113.9 122.8%  
Exports to sales %031.1 0.0%   
Imports to sales %14.311.9 120.2%   
Exports (fob) Rs mNA72,862 0.0%   
Imports (cif) Rs m21,86927,965 78.2%   
Fx inflow Rs m63,06577,245 81.6%   
Fx outflow Rs m21,86931,524 69.4%   
Net fx Rs m41,19645,721 90.1%   
CASH FLOW
From Operations Rs m21,04150,165 41.9%  
From Investments Rs m11,544-32,116 -35.9%  
From Financial Activity Rs m-8,683-29,693 29.2%  
Net Cashflow Rs m23,729-11,674 -203.3%  

Share Holding

Indian Promoters % 75.0 48.8 153.8%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 15.5 38.0 40.9%  
FIIs % 2.6 21.4 12.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.2 51.9%  
Shareholders   408,231 358,459 113.9%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Cadila Healthcare vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Aurobindo Pharma Share Price Performance

Period Cadila Healthcare Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 1.03% 0.25% -0.10%
1-Month -4.82% -15.66% -1.99%
1-Year -9.74% -30.20% -5.62%
3-Year CAGR 17.20% 1.45% 20.96%
5-Year CAGR -0.41% -6.95% 11.47%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

Aurobindo Pharma paid Rs 9.0, and its dividend payout ratio stood at 19.7%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.